TCWM
CAPR icon

Total Clarity Wealth Management’s Capricor Therapeutics CAPR Stock Holding History

Total Clarity Wealth Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-75
Closed – – 989
2021
Q3 		$0 Buy
+75
New +$342 ﹤0.01% 973

Other funds holding CAPR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Total Clarity Wealth Management's CAPR Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Capricor Therapeutics (CAPR) in Q4 2021, closing a stake of 75 shares.

Total Clarity Wealth Management first reported a position in CAPR in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 25 funds tracked by Wall St. Rank hold CAPR as of Q4 2021.

  • Total Clarity Wealth Management reported no remaining Capricor Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 75 Capricor Therapeutics shares in Q4 2021.
  • Total Clarity Wealth Management first reported a position in Capricor Therapeutics in Q3 2021 and held it in 1 quarter.
  • Total Clarity Wealth Management's Capricor Therapeutics position peaked at $0 in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.